Evidence map›Paper›PMID 39177677›Full record

ArticleNatural products and bioprospecting2024

Micro-scale screening of genetically modified Fusarium fujikuroi strain extends the apicidin family.

Alica Fischle, Mika Lutsch, Florian Hübner, Linda Schäker-Hübner, Lina Schürmann, Finn K Hansen, Svetlana A Kalinina

Abstract read
In one paragraph

Article in Natural products and bioprospecting, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Recent Updates on the Secondary Metabolites fromJournal of fungi (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alica Fischle *Institute of Food Chemistry, University of Münster, Corrensstraße 45, 48149, Münster, Germany.
Mika Lutsch *Institute of Food Chemistry, University of Münster, Corrensstraße 45, 48149, Münster, Germany.
Florian HübnerInstitute of Food Chemistry, University of Münster, Corrensstraße 45, 48149, Münster, Germany.
Linda Schäker-HübnerPharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, An Der Immenburg 4, 53121, Bonn, Germany.
Lina SchürmannInstitute of Food Chemistry, University of Münster, Corrensstraße 45, 48149, Münster, Germany.
Finn K HansenPharmaceutical Institute, Pharmaceutical and Cell Biological Chemistry, University of Bonn, An Der Immenburg 4, 53121, Bonn, Germany.
Svetlana A KalininaInstitute of Food Chemistry, University of Münster, Corrensstraße 45, 48149, Münster, Germany. s_kali03@uni-muenster.de.ORCID http://orcid.org/0000-0001-7564-8213

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apicidins are a class of naturally occurring cyclic tetrapeptides produced by few strains within the Fusarium genus. These secondary metabolites have gained significant attention due to their antiprotozoal activity through HDAC inhibition, thereby highlighting their potential for the treatment of malaria. Predominantly, apicidins have been isolated from Fusarium semitectum, offering a deep insight into the biosynthetic pathway responsible for their formation. A similar biosynthetic gene cluster has also been identified in the rice pathogenic fungus F. fujikuroi, leading the discovery of three additional apicidins through genetic manipulation. Routine mass spectrometric screening of these compound-producing strains revealed another metabolite structurally related to previously studied apicidins. By optimizing culture conditions and developing an effective isolation method, we obtained a highly pure substance, whose chemical structure was fully elucidated using NMR and HRMS fragmentation. Further studies were conducted to determine cytotoxicity, antimalarial activity, and HDAC inhibitory activity of this new secondary metabolite alongside the previously known apicidins. This work not only expands the apicidin class with a new member but also provides extensive insights and comparative analysis of apicidin-like substances produced by F. fujikuroi.

Indexed as

ApicidinsCyclic tetrapeptidesCytotoxicityHDAC inhibitionTropical diseases

Identifiers

PMID39177677
PMCPMC11343938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.